Biopharma

• 10/7/2024

  **Underwhelming Profile: Third Harmonic**

• 

  10/4/2024

  **Mirum Pharmaceuticals: Wait for Data Before Buying**

• 9/30/2024

  **Erasca’s New Direction: Seeking Unique Identity**